MPARK Stock Overview
MLP Saglik Hizmetleri A.S. provides healthcare service in Turkey.
MLP Saglik Hizmetleri Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||₺33.90|
|52 Week High||₺40.48|
|52 Week Low||₺21.34|
|1 Month Change||-4.51%|
|3 Month Change||11.08%|
|1 Year Change||50.80%|
|3 Year Change||193.00%|
|5 Year Change||n/a|
|Change since IPO||80.80%|
Recent News & Updates
|MPARK||TR Healthcare||TR Market|
Return vs Industry: MPARK exceeded the TR Healthcare industry which returned -27.5% over the past year.
Return vs Market: MPARK underperformed the TR Market which returned 61.2% over the past year.
|MPARK Average Weekly Movement||5.3%|
|Healthcare Industry Average Movement||5.3%|
|Market Average Movement||5.9%|
|10% most volatile stocks in TR Market||8.7%|
|10% least volatile stocks in TR Market||4.1%|
Stable Share Price: MPARK is not significantly more volatile than the rest of TR stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: MPARK's weekly volatility (5%) has been stable over the past year.
About the Company
MLP Saglik Hizmetleri A.S. provides healthcare service in Turkey. The company operates diagnosis and treatment units. It operates 30 hospitals with 6,000 beds in 15 cities under the Liv Hospital, VM Medical Park and Istinye University Hospital names.
MLP Saglik Hizmetleri Fundamentals Summary
|MPARK fundamental statistics|
Is MPARK overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|MPARK income statement (TTM)|
|Cost of Revenue||₺4.91b|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||1.90|
|Net Profit Margin||5.83%|
How did MPARK perform over the long term?See historical performance and comparison
Is MPARK undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 4/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for MPARK?
Other financial metrics that can be useful for relative valuation.
|What is MPARK's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does MPARK's PE Ratio compare to its peers?
|MPARK PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
Price-To-Earnings vs Peers: MPARK is good value based on its Price-To-Earnings Ratio (17.9x) compared to the peer average (31x).
Price to Earnings Ratio vs Industry
How does MPARK's PE Ratio compare vs other companies in the Healthcare Industry?
Price-To-Earnings vs Industry: MPARK is expensive based on its Price-To-Earnings Ratio (17.9x) compared to the TR Healthcare industry average (17.9x)
Price to Earnings Ratio vs Fair Ratio
What is MPARK's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||17.9x|
|Fair PE Ratio||13x|
Price-To-Earnings vs Fair Ratio: MPARK is expensive based on its Price-To-Earnings Ratio (17.9x) compared to the estimated Fair Price-To-Earnings Ratio (13x).
Share Price vs Fair Value
What is the Fair Price of MPARK when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: MPARK (TRY33.9) is trading below our estimate of fair value (TRY65.7)
Significantly Below Fair Value: MPARK is trading below fair value by more than 20%.
Price to Earnings Growth Ratio
PEG Ratio: MPARK is good value based on its PEG Ratio (0.7x)
Discover undervalued companies
How is MLP Saglik Hizmetleri forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?
Future Growth Score5/6
Future Growth Score 5/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MPARK's forecast earnings growth (27.1% per year) is above the savings rate (9%).
Earnings vs Market: MPARK's earnings (27.1% per year) are forecast to grow faster than the TR market (16.1% per year).
High Growth Earnings: MPARK's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: MPARK's revenue (18.2% per year) is forecast to grow faster than the TR market (13.8% per year).
High Growth Revenue: MPARK's revenue (18.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MPARK's Return on Equity is forecast to be very high in 3 years time (53.7%).
Discover growth companies
How has MLP Saglik Hizmetleri performed over the past 5 years?
Past Performance Score5/6
Past Performance Score 5/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: MPARK has high quality earnings.
Growing Profit Margin: MPARK's current net profit margins (5.8%) are higher than last year (1.9%).
Past Earnings Growth Analysis
Earnings Trend: MPARK has become profitable over the past 5 years, growing earnings by 67.1% per year.
Accelerating Growth: MPARK's earnings growth over the past year (392.2%) exceeds its 5-year average (67.1% per year).
Earnings vs Industry: MPARK earnings growth over the past year (392.2%) exceeded the Healthcare industry 169.5%.
Return on Equity
High ROE: Whilst MPARK's Return on Equity (55.02%) is outstanding, this metric is skewed due to their high level of debt.
Discover strong past performing companies
How is MLP Saglik Hizmetleri's financial position?
Financial Health Score3/6
Financial Health Score 3/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: MPARK's short term assets (TRY3.1B) do not cover its short term liabilities (TRY3.7B).
Long Term Liabilities: MPARK's short term assets (TRY3.1B) exceed its long term liabilities (TRY1.7B).
Debt to Equity History and Analysis
Debt Level: MPARK's net debt to equity ratio (94.3%) is considered high.
Reducing Debt: MPARK's debt to equity ratio has reduced from 387.4% to 169.5% over the past 5 years.
Debt Coverage: MPARK's debt is well covered by operating cash flow (123.8%).
Interest Coverage: MPARK's interest payments on its debt are not well covered by EBIT (2.1x coverage).
Discover healthy companies
What is MLP Saglik Hizmetleri current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate MPARK's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate MPARK's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if MPARK's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if MPARK's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as MPARK has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Muharrem Usta (56 yo)
Dr. Muharrem Usta has been Chairman of the Executive Board at Trabzonspor Sportif Yatirim ve Futbol Isletmeciligi Ticaret A.S since February 02, 2016 and served as its Director until 2018. Dr. Usta served...
Experienced Board: MPARK's board of directors are considered experienced (8.1 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
MLP Saglik Hizmetleri A.S.'s employee growth, exchange listings and data sources
- Name: MLP Saglik Hizmetleri A.S.
- Ticker: MPARK
- Exchange: IBSE
- Founded: 1993
- Industry: Health Care Facilities
- Sector: Healthcare
- Implied Market Cap: ₺7.052b
- Shares outstanding: 208.04m
- Website: https://www.mlpcare.com
Number of Employees
- MLP Saglik Hizmetleri A.S.
- Haliç Otakçilar Cad. No: 78
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/06/26 00:00|
|End of Day Share Price||2022/06/24 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.